The Singapore facility is part of Sanofi's 900 million euro investment to develop two new EVFs globally over five years. The ...

By 2035, the medium-term goals include increasing local production to 75% and developing research partnerships to secure approval for additional vaccines ...

SANOFI added a new plant in Singapore to make vaccines and other medicines, as the French pharmaceutical group seeks to ...

India presently represents 3-4% of global biosimilar production, second to China and aims to increase it significantly. With ...

President-elect Donald Trump has chosen health economist Dr. Jay Bhattacharya, a critic of pandemic lockdowns and vaccine ...

Bhattacharya said he wants to reform the US medical research agency and restore public trust in scientific institutions. View ...